Aurora sponsors cancer-pain study featuring MedReleaf capsules. Continue reading Aurora Cannabis sponsors cancer-pain study directed by internationally acclaimed oncologist.
Approximately 60 patients suffering breakthrough cancer pain to participate in clinical trial that compares fentanyl with inhaled medical cannabis. Continue reading UPDATED: Cannabis vs. fentanyl for cancer pain; clinical trial
Heath Canada decision to reclassify, to a Phase Two medical device, the @TetraBioPharma inhalation pipe for cannabis medication means that patients suffering cancer pain may soon be able to claim the cost through their private and public insurance plans. Continue reading Health Canada makes Tetra Bio-Pharma cannabis-delivery product a Class Two medical device.
TetraBioPharma is setting its sights on cannabinoid-based drugs for rare cancers and eye diseases as it moves deeper into US with multiple FDA submissions. #cannabis #cannabis4cancer #cannabiscures Continue reading Tetra targets rare cancers & eye disease in FDA submissions
“The literature is nearly unanimous in suggesting that cannabinoids and endocannabinoids reduce the progression of cancer in preclinical model systems,” Continue reading Research spanning multiple decades suggests cannabis as potential cancer medicine.
A cannabis-derived drug that could reduce opioid fentanyl use for breakthrough cancer pain is one step closer thanks to Health Canada approval that will allow a clinical trial to begin in October. Continue reading Clinical trial will compare cannabis with fentanyl for rapid-onset cancer pain